These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21610723)

  • 1. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
    Kaur J; Tuor UI; Zhao Z; Barber PA
    J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G; Zhang Z; Chopp M; Li L; Zhang L; Li Q; Wei M; Jiang Q
    Neuroscience; 2014 Jun; 271():1-8. PubMed ID: 24769225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator prevents restoration of tight junction proteins through upregulation of angiopoietin-2.
    Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
    Curr Neurovasc Res; 2013 Feb; 10(1):39-48. PubMed ID: 23151074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult.
    Jiao H; Wang Z; Liu Y; Wang P; Xue Y
    J Mol Neurosci; 2011 Jun; 44(2):130-9. PubMed ID: 21318404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.
    Liu J; Jin X; Liu KJ; Liu W
    J Neurosci; 2012 Feb; 32(9):3044-57. PubMed ID: 22378877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling.
    Liu X; Wang Z; Wang P; Yu B; Liu Y; Xue Y
    BMC Complement Altern Med; 2013 Jul; 13():187. PubMed ID: 23870286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA.
    Li C; Wang C; Zhang Y; Alsrouji OK; Chebl AB; Ding G; Jiang Q; Mayer SA; Lu M; Kole MK; Marin HL; Zhang L; Chopp M; Zhang ZG
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2090-2104. PubMed ID: 33557693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
    Simpkins AN; Dias C; Leigh R;
    Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK; Tuor UI; Rushforth D; Barber PA
    Ther Hypothermia Temp Manag; 2015 Dec; 5(4):203-8. PubMed ID: 26075540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.